Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4

JAMA Ophthalmology

Volumn 131, Issue 7, 2013, Pages 843-850

  Chew, Emily Y ^a   SanGiovanni, John Paul ^a   Ferris, Frederick L ^a   Wong, W T ^a   Agron, Elvira ^a   Clemons, Traci E ^b   Sperduto, Robert ^b   Danis, Ronald ^c   Chandra, Suresh R ^c   Blodi, Barbara A ^c   Domalpally, Amitha ^c   Elman, Michael J ^d   Antoszyk, Andrew N ^e   Ruby, Alan J ^f   Orth, David ^g   Bressler, Susan B ^h   Fish, Gary E ^e   Hubbard, George B ⁱ   Klein, Michael L ^j   Friberg, Thomas R ^k   Rosenfeld, Philip J ^l   Toth, Cynthia A ^m   Bernstein, Paul ⁿ   more..

^a NATIONAL EYE INSTITUTE   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Elman Retina Group   (United States)

^e Vision Research Foundation ^*

^f Vision Research Foundation   (United States)

^g Ingalls Memorial Hospital   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ EMORY EYE CENTER   (United States)

^j Ocular Biomechanics Laboratory Devers   (United States)

^k UNIVERSITY OF PITTSBURGH   (United States)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^m DUKE UNIVERSITY   (United States)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PLACEBO; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; APHAKIA; ARTICLE; CATARACT EXTRACTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSEUDOPHAKIA; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SENILE CATARACT;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AGING; CATARACT; CATARACT EXTRACTION; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LUTEIN; MALE; VISION DISORDERS; VISUAL ACUITY; XANTHOPHYLLS;

EID: 84880312820     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.4412     Document Type: Article

References (36)

1. Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11(2):67-115.
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-851.
3. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4): 477-485.
4. Congdon N, Vingerling JR, Klein BE, et al; Eye Diseases Prevalence Research Group. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004;122(4):487-494.
5. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol. 1991;109(2):244-251.
6. Seddon JM, ChristenWG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health. 1994;84(5):788-792.
7. Leske MC, Chylack LT Jr, He Q, et al. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmology. 1998;105(5): 831-836.
8. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol. 2000;118(11):1556-1563.
9. Jacques PF, Chylack LT Jr, Hankinson SE, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol. 2001;119(7):1009-1019.
10. KuzniarzM, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol. 2001;132(1):19-26.
11. Teikari JM, Virtamo J, RautalahtiM, Palmgren J, Liesto K, Heinonen OP. Long-term supplementation with alpha-tocopherol and beta-carotene and age-related cataract. Acta Ophthalmol Scand. 1997;75(6):634-640.
12. ChristenWG, Manson JE, Glynn RJ, et al. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol. 2003;121(3):372-378.
13. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies: two nutrition intervention trials. Arch Ophthalmol. 1993;111(9):1246-1253.
14. McNeil JJ, Robman L, Tikellis G, SinclairMI, McCarty CA, Taylor HR. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology. 2004;111(1):75-84.
15. ChristenW, Glynn R, Sperduto R, Chew E, Buring J. Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiol. 2004;11(5):401-412.
16. Gritz DC, Srinivasan M, Smith SD, et al. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90(7):847-851.
17. Maraini G, Williams SL, Sperduto RD, et al; Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities: clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology. 2008;115(4):599-607.
18. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119(10):1439-1452.
19. Dorey CK, Granata L, Nichols CR, Cheng KM, Craft NE. Dietary modulation of lens zeaxanthin in quail. Exp Eye Res. 2005;81(4):464-477.
20. Yeum KJ, Taylor A, Tang G, Russell RM. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest Ophthalmol Vis Sci. 1995;36(13):2756-2761.
21. Delcourt C, Carrière I, DelageM, Barberger-Gateau P, SchalchW; POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci. 2006;47(6):2329-2335.
22. Moeller SM, Voland R, Tinker L, et al; CAREDS Study Group;Women's Health Initiative. Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an ancillary study of theWomen's Health Initiative. Arch Ophthalmol. 2008;126(3):354-364.
23. Vu HT, Robman L, Hodge A, McCarty CA, Taylor HR. Lutein and zeaxanthin and the risk of cataract: the Melbourne Visual Impairment Project. Invest Ophthalmol Vis Sci. 2006;47(9):3783-3786.
24. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr. 1999;70(4):517-524.
25. Chew EY, Clemons T, SanGiovanni JP, et al; The AREDS2 Research Group. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119(11):2282-2289.
26. Hambidge M. Underwood Memorial Lecture: human zinc homeostasis: good but not perfect. J Nutr. 2003;133(5, supp 1):1438S-1442S.
27. Wei LJ, Jin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J AmStat Assoc. 1989;84(408):1065. doi:10. 2307/2290084.
28. ChristenWG, Liu S, Glynn RJ, Gaziano JM, Buring JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol. 2008;126(1):102-109.
29. WillettWC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol. 1988;127(1):188-199.
30. Milton RC, Sperduto RD, Clemons TE, Ferris FL III; Age-Related Eye Disease Study Research Group. Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach: AREDS report No 21. Ophthalmology. 2006;113(8):1264-1270.
31. Yeum KJ, Russell RM. Carotenoid bioavailability and bioconversion. Annu Rev Nutr. 2002;22: 483-504.
32. Kostic D, WhiteWS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr. 1995;62(3): 604-610.
33. Wang Y, Roger Illingworth D, Connor SL, Barton Duell P, Connor WE. Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene. Eur J Nutr. 2010;49(6):327-336.
34. Adamsons I, Muñoz B, Enger C, Taylor HR. Prevalence of lens opacities in surgical and general populations. Arch Ophthalmol. 1991;109(7): 993-997.
35. Lewis A, Congdon N, Munoz B, et al. Cataract surgery and subtype in a defined, older population: the SEECAT Project. Br J Ophthalmol. 2004;88(12): 1512-1517.
36. Taylor A. Cataract: relationship between nutrition and oxidation. J AmColl Nutr. 1993;12(2): 138-146.